Purpose: We examined health care seeking activities during a 12-month period in a cohort of men and women with urological chronic pelvic pain syndromes. Materials and Methods: A total of 191 men and 233 women with urological chronic pelvic pain syndrome were followed with biweekly, Internet based questionnaires about symptoms and health care seeking activities, including 1) health care provider contacts, 2) office visits, 3) emergency room/urgent care visits, 4) medication changes and 5) medical procedures. Multivariable modeling was used to determine the association of demographic and clinical variables with health care seeking. Super users were defined as individuals who reported health care seeking activity at least 11 times during the 23 biweekly assessments. Results: Health care seeking activities included a mean of 2.4 office contacts, 2.5 office visits, 1.9 medication changes, 0.9 medical procedures and 0.3 emergency room/urgent care visits. A total of 31 health care seeking super users accounted for 26% of health care seeking activities. Worse baseline pain severity and female gender were associated with a higher rate of all health care seeking activities except emergency room/urgent care visits. A nonurological chronic pain condition was associated with more provider contacts, office visits and medical procedures. Greater baseline depression symptoms were associated with more provider contacts, office visits and medication changes. Other examined variables, including patient age, symptom duration, catastrophizing, anxiety, urinary symptom severity and symptom variability, had a minimal association with health care seeking. Conclusions: Health care seeking activities were strongly influenced by the severity of pain in patients with urological chronic pelvic pain syndromes but not Accepted for publication December 26, 2017. No direct or indirect commercial incentive associated with publishing this article. The corresponding author certifies that, when applicable, a statement(s) has been included in the manuscript documenting institutional review board, ethics committee or ethical review board study approval; principles of Helsinki Declaration were followed in lieu of formal ethics committee approval; institutional animal care and use committee approval; all human subjects provided written informed consent with guarantees of confidentiality; IRB approved protocol number; animal approved project number.
by urinary symptom severity. Women and patients with nonurological overlapping pain conditions were more likely to be seen and treated for symptoms.
Key Words: urinary bladder; prostate; cystitis, interstitial; pelvic pain; patient acceptance of health care THE term UCPPS includes IC/BPS and CP/CPPS. 1 UCPPS symptoms are characterized by bladder pain, pelvic pain and/or urinary symptoms such as abnormal frequency and nocturia. The etiology of these symptoms is poorly understood and likely heterogeneous. Although there are many UCPPS treatments, none is consistently effective. As a result patients with UCPPS typically have multiple physician office visits and undergo numerous treatments in an attempt to improve the symptoms. 2, 3 Not surprisingly patients with UCPPS make up a significant proportion (5% to 15%) of urology office visits. 4e6 However, the type and frequency of HCS activities as well as the predictors of care seeking by these patients has not been well described.
We studied men and women with UCPPS to assess HCS activities and prospectively examined the association of a wide range of clinical and demographic factors with increased health care seeking behaviors.
METHODS

Subject Recruitment
This study was done as part of the MAPP Research Network. At the 6 MAPP Research Network clinical centers a total of 191 men and 233 women with UCPPS were enrolled in a 12-month prospective, observational cohort study. Study design, and inclusion and exclusion criteria were previously described in detail. 7 Study entry criteria were broad to permit the recruitment of participants with a range of symptoms and symptom severities. Study inclusion required a clinical diagnosis of IC/BPS or CP/ CPPS and a pain score of at least 1 on a Likert pain scale. Women were eligible if they endorsed a sensation of pain, pressure or discomfort localized in the bladder or pelvic region which was associated with lower urinary tract symptoms. Men were eligible if they met the same eligibility criteria as those for IC/BPS or either of 2 CP/CPPS specific eligibility criteria, including 1) self-reported pain or discomfort in the perineum, suprapubic area, testicles or tip of the penis or 2) self-reported pain associated with urination or ejaculation.
Participants underwent an in-depth baseline evaluation. To account for regression to the mean we used a 4-week runin period so that week 4 data were defined as baseline values for analytical purposes. 8 Less comprehensive assessments were performed at the 6 and 12-month followup visits. 7 Study participants also completed biweekly internet based questionnaires about symptoms and health care seeking.
Demographic and Clinical Factors
Patient age, gender, self-reported UCPPS symptom duration and the presence of 3 other COPCs, including fibromyalgia, irritable bowel syndrome or chronic fatigue syndrome, were also self-reported by study participants at baseline. Separate scores for UCPPS pain severity and urinary severity were obtained from biweekly responses to the GUPI (Genitourinary Pain Index) 9 and the ICSI (Interstitial Cystitis Symptom Index) 10 as reported previously. 11 At the time of each biweekly assessment within person pain and urological symptom variability was determined based on the SD of pain scores and urinary scores, respectively, for the preceding 6-week period. 8 
Psychosocial Factors
Catastrophizing was measured with the 6-item CSQ catastrophizing subscale. 12 Anxiety and depression were assessed by the HADS. 13 
Health Care Seeking Behaviors
Subjects were asked biweekly if urological or pelvic pain symptoms had been severe enough to cause them to seek medical care in the last 2 weeks, including 1) contacting a health care provider (physician, nurse, physical therapist or other provider) by telephone or e-mail, 2) seeing a health care provider in the office, 3) making a trip to an ER or urgent care center, 4) having a medication changed (new medication or different dose) or 5) undergoing a medical procedure. For each HCS activity we defined a super user as any individual who reported HCS at least 11 times during the 23 biweekly assessments. This value was chosen as it represented half of the 22 followup HCS assessments that occurred after the baseline visit. ER/urgent care visits were not included in this super user analysis due to the small number of observed events in that category.
Statistical Analysis
We determined the number of times that each participant engaged in each HCS activity during the 48-week followup. Univariable and multivariable Poisson models with the log of the number of survey completions as an offset were used to determine the association of demographic and clinical variables with the rate of each HCS behavior for 48 weeks. The models included gender, age, presence of any COPC, symptom duration (2 or more vs less than 2 years), baseline (pain/urinary) symptom severity, CSQ catastrophizing score, and HADS anxiety and depression scores. To assess the impact of time varying symptom levels and variability on the likelihood of reporting engaging in each HCS behavior we fit univariable and multivariable logistic models by generalized estimating equations to account for the within patient correlation among biweekly observations. An independence working correlation was assumed and robust variance estimators were used for statistical inference. These models included within person pain/urinary symptom variability and symptom severity at the prior contact as predictors. All models were also adjusted for site to account for potential site differences. Analyses were performed with SAS/STATÒ, version 9.3.
RESULTS
Baseline characteristics of the 424 MAPP participants were previously reported.
14 Mean age of the 191 male participants was 46.8 years (range 19 to 82) and mean UCPPS symptom history was 7.8 years (range 0 to 54). Mean age of the 233 female participants was 40.5 years (range 19 to 78) and mean symptom history was 9.1 years (range 0 to 47). Each study participant was eligible to complete 23 HCS surveys between weeks 4 and 52 during the 12-month study period. A mean of 15.0 surveys (median 16) were completed. At least 10 survey responses were received from 313 study participants (74%). Fewer than 3 surveys were completed by 36 study participants (8.5%) and they were excluded from analysis.
Between weeks 4 and 52 the mean values of HCS activities were 2.4 office contacts, 2.5 office visits, 1.9 medication changes, 0.9 medical procedures and 0.3 ER/urgent care visits (table 1). The range of values of each HCS activity was large, indicating significant variability across individuals regarding the use of medical resources. HCS was more common in women than men across all categories.
Supplementary tables 1 to 4 (http://jurology.com/) show the results of univariable and multivariable analyses of HCS activities. Worse baseline pain severity and female gender were associated with an increased rate of all HCS activities except ER/urgent care visits. A second (nonurological) COPC was associated with more provider contacts, office visits and medical procedures while a higher HADS depression score was associated with more provider contacts, office visits and medication changes. Other examined variables, including age, symptom duration, catastrophizing score, anxiety score, baseline urinary symptom severity, most recent urinary symptom severity, pain symptom variability and urinary symptom variability, had no or minimal association with HCS activities. Higher (worse) pain severity at the most recent contact strongly predicted HCS across all models. It was the only variable associated with increased ER/urgent care visits.
A total of 31 study participants (7.
DISCUSSION
During the course of this 12-month prospective cohort study participants with UCPPS reported an average of 2.4 provider contacts, 2.5 office visits, 1.9 medication changes and 0.9 medical procedures specifically for UCPPS symptoms. ER/urgent care visits were much less common, perhaps reflecting the chronic nature of participant symptoms. To meet study inclusion criteria all MAPP subjects were required to have an established UCPPS diagnosis of IC/BPS or CP/CPPS. Therefore, our cohort did not include patients with new onset UCPPS symptoms, who often see numerous physicians and undergo multiple tests before being diagnosed and/ or referred for specialty care. On the other hand, patients with longstanding UCPPS symptoms such as the MAPP participants may not seek health care less than those with new onset symptoms due to the chronic and persistent nature of the disorder.
The most powerful predictor of increased HCS activities was UCPPS pain symptom severity at the most recent contact, which was typically 2 weeks preceding the HCS assessment. More severe antecedent pain symptoms were associated with a significant increase in all measured HCS activities. More severe baseline pain severity also correlated with a higher rate of HCS activities. In contrast, urinary symptom severity, whether measured at baseline or at the most recent contact, was not associated with HCS. These findings suggest that pain symptoms and urinary symptoms have a different impact on patients since pain appeared to trigger office visits and treatment changes while urinary symptoms did not. The reason for this is not clear. Perhaps patients self-treated for urinary symptoms or maybe they were provided with therapies to use as needed (eg antibiotics or urinary analgesics) that did not prompt a new provider interaction. These findings reinforced our previous observations that pain symptoms and urinary symptoms in UCPPS are separate, unique constructs of these syndromes.
11,15
We identified distinct gender differences in HCS. Women with UCPPS performed many more HCS activities than men even after controlling for symptom severity, age, and other clinical and demographic factors. This was unexpected because our previous findings suggested that gender has a minimal impact on UCPPS symptom trajectory. 15 By definition all women in the MAPP cohort were diagnosed with IC/BPS while men may have had IC/BPS or CP/CPPS. Therefore, female MAPP participants showed more bladder centric symptoms than male participants. 16 This could potentially have had an impact on HCS as bladder centric symptoms could increase the likelihood of certain treatments/procedures to manage pain (eg cystoscopy and bladder instillations). Alternatively there may have been unmeasured clinical, demographic or psychosocial differences between the genders or between IC/BPS and CP/CPPS to account for the observed discrepancy in HCS, as has been demonstrated for other health conditions. 17 We expected that increased UCPPS symptom variability would result in increased HCS since variable/unpredictable symptoms would be expected to cause more bother to patients. However, we observed no association between symptom variability and HCS. It is possible that our biweekly measurements were too infrequent to accurately capture UCPPS symptom variability as focus group studies have indicated that UCPPS symptoms can fluctuate throughout the day. 18 We are currently developing a process to gather symptom data on a daily basis using mobile smartphone platforms to further investigate this issue.
The presence of another COPC was associated with more office contacts, office visits and medical procedures for UCPPS. It is possible that the increased symptom burden of multiple COPCs leads these individuals to feel less well and more chronically compromised. It is also possible that patients with these overlapping conditions have a larger team of health care providers, resulting in more HCS when participants are symptomatic. Another possibility is that some reported HCS activities may have been due to symptoms of the other nonurological pain conditions, given the inherent symptomatic overlap that exists among many of these chronic pain conditions.
Psychosocial factors are known to relate to quality of life and other outcomes related to chronic pain. These observations are consistent with our finding that increased depression symptoms were associated with more provider contacts, office visits and medication changes for UCPPS symptoms. However, other measured psychosocial variables such as catastrophizing symptoms and anxiety had no association with HCS activities.
We identified 31 HCS super users, representing approximately 7% of the total MAPP cohort, who accounted for 26% of reported HCS activities. Female gender, worse baseline pain severity and more severe depressive symptoms were associated with HCS super user status, consistent with our findings that these factors predicted overall HCS activity in the MAPP cohort. In contrast, increased age was a predictor of super user status but not predictive of HCS across the entire network. In addition, the presence of a nonurological COPC was not associated with super user status but it was associated with increased HCS. These findings suggest that extreme HCS behavior is more common as patients age and it is unrelated to the presence of nonurological pain symptoms.
Finally, the inverse association between baseline urinary symptom severity and super user status is counterintuitive. It suggests that perhaps a subset of patients with severe pain and minimal urinary symptoms may account for a disproportionate number of health care activities for UCPPS. However, univariate results indicated a positive association between urinary symptom severity and super user status (table 3) . This implies that the multivariable results may reflect an association among other variables in the model rather than specifically with care seeking activities. Certain limitations of our analysis should be acknowledged. The MAPP cohort represents a select group of patients with UCPPS who were recruited from academic tertiary care centers and may not reflect the clinical and demographic characteristics of the broader UCPPS population. Some participants did not complete all biweekly assessments so that these biweekly assessments could not identify whether multiple HCS activities in the same category, such as office visits, occurred during the 2-week period. These 2 limitations would tend to have resulted in underestimating the degree of HCS in the cohort. In addition, we did not collect data on costs, which would have provided a more comprehensive assessment of medical resource use.
Nevertheless, to our knowledge this is the first study to prospectively examine HCS activities in a cohort of patients with UCPPS. The inclusion of multiple clinical sites, and extensive clinical and demographic data on the participants are strengths which help provide valuable insights into HCS behaviors and predictors.
CONCLUSIONS
To our knowledge this is the first study to prospectively examine the type and frequency of HCS activities of a cohort of patients with UCPPS. UCPPS symptoms accounted for an average of 2.4 provider contacts, 2.5 office visits, 1.9 medication changes and 0.9 medical procedures in 12 months. HCS activities were strongly influenced by UCPPS pain severity but not by urinary symptom severity. Women were more likely than men to be seen and treated for symptoms. Approximately 7% of the study participants were health care super users who accounted for 26% of the care seeking activities.
